Provider: Ingenta Connect Database: Ingenta Connect Content: application/x-research-info-systems TY - ABST AU - Prendergast, Catriona T. AU - Anderton, Stephen M. TI - Immune Cell Entry to Central Nervous System - Current Understanding and Prospective Therapeutic Targets JO - Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) PY - 2009-12-01T00:00:00/// VL - 9 IS - 4 SP - 315 EP - 327 UR - https://www.ingentaconnect.com/content/ben/emiddt/2009/00000009/00000004/art00001 ER - TY - ABST AU - Breckpot, Karine AU - Escors, David TI - Dendritic Cells for Active Anti-Cancer Immunotherapy: Targeting Activation Pathways Through Genetic Modification JO - Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) PY - 2009-12-01T00:00:00/// VL - 9 IS - 4 SP - 328 EP - 343 UR - https://www.ingentaconnect.com/content/ben/emiddt/2009/00000009/00000004/art00002 ER - TY - ABST AU - Chhabra, Arvind TI - MHC Class I TCR Engineered Anti-Tumor CD4 T Cells: Implications For Cancer Immunotherapy JO - Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) PY - 2009-12-01T00:00:00/// VL - 9 IS - 4 SP - 344 EP - 352 UR - https://www.ingentaconnect.com/content/ben/emiddt/2009/00000009/00000004/art00003 ER - TY - ABST AU - Dalloul, Ali AU - Sainz-Perez, Alexander TI - Interleukin-24: A Molecule with Potential Anti-Cancer Activity and a Cytokine in Search of a Function JO - Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) PY - 2009-12-01T00:00:00/// VL - 9 IS - 4 SP - 353 EP - 360 UR - https://www.ingentaconnect.com/content/ben/emiddt/2009/00000009/00000004/art00004 ER - TY - ABST AU - Chen, Ling-Yu AU - Pan, Zhixing K. TI - Synergistic Activation of Leukocytes by Bacterial Chemoattractants: Potential Drug Targets JO - Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) PY - 2009-12-01T00:00:00/// VL - 9 IS - 4 SP - 361 EP - 370 UR - https://www.ingentaconnect.com/content/ben/emiddt/2009/00000009/00000004/art00005 ER - TY - ABST AU - Ng, K. W. TI - Future Developments in Osteoporosis Therapy JO - Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) PY - 2009-12-01T00:00:00/// VL - 9 IS - 4 SP - 371 EP - 384 UR - https://www.ingentaconnect.com/content/ben/emiddt/2009/00000009/00000004/art00006 ER - TY - ABST AU - Vashishta, Aruna AU - Ohri, Sujata S. AU - Vetvicka, Vaclav TI - Pleiotropic Effects of Cathepsin D JO - Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) PY - 2009-12-01T00:00:00/// VL - 9 IS - 4 SP - 385 EP - 391 UR - https://www.ingentaconnect.com/content/ben/emiddt/2009/00000009/00000004/art00007 ER - TY - ABST AU - Poh, Z. X. AU - Goh, K. P. TI - A Current Update on the Use of Alpha Lipoic Acid in the Management of Type 2 Diabetes Mellitus JO - Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders) PY - 2009-12-01T00:00:00/// VL - 9 IS - 4 SP - 392 EP - 398 UR - https://www.ingentaconnect.com/content/ben/emiddt/2009/00000009/00000004/art00008 ER -